203 related articles for article (PubMed ID: 24252932)
61. Loss of p21WAF1/CIP1 expression in invasive fronts of oral tongue squamous cell carcinomas is correlated with tumor progression and poor prognosis.
Goto M; Tsukamoto T; Inada K; Mizoshita T; Ogawa T; Terada A; Hyodo I; Shimozato K; Hasegawa Y; Tatematsu M
Oncol Rep; 2005 Oct; 14(4):837-46. PubMed ID: 16142340
[TBL] [Abstract][Full Text] [Related]
62. The role of BATF2 deficiency in immune microenvironment rearrangement in cervical cancer - New biomarker benefiting from combination of radiotherapy and immunotherapy.
Zong Y; Chang Y; Huang K; Liu J; Zhao Y
Int Immunopharmacol; 2024 Jan; 126():111199. PubMed ID: 37995570
[TBL] [Abstract][Full Text] [Related]
63. Single-cell RNA sequencing reveals the heterogeneity of epithelial cell and fibroblast cells from non- to metastatic lymph node OTSCC.
Song D; Yang F; Sun Y; Wu X; Zhou Q; Bi W; Sun J; Li S; Yu Y
FASEB J; 2024 Jan; 38(1):e23390. PubMed ID: 38169064
[TBL] [Abstract][Full Text] [Related]
64. hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2).
Li Q; Sun H; Shu Y; Zou X; Zhao Y; Ge C
Cell Prolif; 2015 Aug; 48(4):436-42. PubMed ID: 26032517
[TBL] [Abstract][Full Text] [Related]
65. High expression of FMNL3 associates with cancer cell migration, invasion, and unfavorable prognosis in tongue squamous cell carcinoma.
Liu J; Chen S; Chen Y; Geng N; Feng C
J Oral Pathol Med; 2019 Jul; 48(6):459-467. PubMed ID: 30955218
[TBL] [Abstract][Full Text] [Related]
66. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
67. Multicenter retrospective analysis of clinicopathological features and prognosis of oral tongue squamous cell carcinoma in adolescent and young adult patients.
Okuyama K; Yanamoto S; Michi Y; Shibata E; Tsuchiya M; Yokokawa M; Naruse T; Tomioka H; Kuroshima T; Shimamoto H; Ikeda T; Umeda M; Yoda T; Harada H
Medicine (Baltimore); 2021 Oct; 100(41):e27560. PubMed ID: 34731158
[TBL] [Abstract][Full Text] [Related]
68. FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment.
Zhong Z; Zhang H; Hong M; Sun C; Xu Y; Chen X; Gao C; He M; Liu W; Liang J
Oncol Rep; 2018 Apr; 39(4):1853-1859. PubMed ID: 29393475
[TBL] [Abstract][Full Text] [Related]
69. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract][Full Text] [Related]
70. Oral tongue squamous cell carcinoma survival as stratified by age and sex: A surveillance, epidemiology, and end results analysis.
Mukdad L; Heineman TE; Alonso J; Badran KW; Kuan EC; St John MA
Laryngoscope; 2019 Sep; 129(9):2076-2081. PubMed ID: 30575045
[TBL] [Abstract][Full Text] [Related]
71. Perineural invasion and expression of nerve growth factor can predict the progression and prognosis of oral tongue squamous cell carcinoma.
Shen WR; Wang YP; Chang JY; Yu SY; Chen HM; Chiang CP
J Oral Pathol Med; 2014 Apr; 43(4):258-64. PubMed ID: 24822265
[TBL] [Abstract][Full Text] [Related]
72. Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
Almangush A; Mäkitie AA; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Salo T; Leivo I
BMC Cancer; 2020 Sep; 20(1):843. PubMed ID: 32883229
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma.
Dai D; Chen H; Tang J; Tang Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):1259-1264. PubMed ID: 27932243
[TBL] [Abstract][Full Text] [Related]
74. Role of plasminogen activator inhibitor-1 in oral tongue squamous cell carcinoma: An immunohistochemical and in vitro analysis.
Mafra RP; Sabino VG; Rolim LSA; de Carvalho CHP; Nonaka CFW; Barboza CAG; de Souza LB; Pinto LP
Exp Mol Pathol; 2022 Feb; 124():104722. PubMed ID: 34800515
[TBL] [Abstract][Full Text] [Related]
75. Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling.
Zheng L; Li N; Guo F; Jian XC; Jiang CH; Yin P; Min AJ; Huang L
Mol Med Rep; 2015 Mar; 11(3):2255-61. PubMed ID: 25378227
[TBL] [Abstract][Full Text] [Related]
76. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma.
Li SH; Chien CY; Huang WT; Luo SD; Su YY; Tien WY; Lan YC; Chen CH
Sci Rep; 2017 Aug; 7(1):8178. PubMed ID: 28811537
[TBL] [Abstract][Full Text] [Related]
77. CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
Chen Y; Tian T; Mao MJ; Deng WY; Li H
BMC Cancer; 2018 May; 18(1):514. PubMed ID: 29720147
[TBL] [Abstract][Full Text] [Related]
78. Obesity enhances the response to neoadjuvant anti-PD1 therapy in oral tongue squamous cell carcinoma.
Tan X; Li G; Deng H; Xiao G; Wang Y; Zhang C; Chen Y
Cancer Med; 2024 Jun; 13(12):e7346. PubMed ID: 38923758
[TBL] [Abstract][Full Text] [Related]
79. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma.
Rapado-González Ó; Costa-Fraga N; Bao-Caamano A; López-Cedrún JL; Álvarez-Rodríguez R; Crujeiras AB; Muinelo-Romay L; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
Oral Dis; 2024 Mar; 30(2):259-271. PubMed ID: 36398465
[TBL] [Abstract][Full Text] [Related]
80. [Expression of p15 and p16 proteins in tongue squamous cell carcinoma and their significances].
Liu XQ; Zeng RS; Huang HZ; Liao GQ
Ai Zheng; 2003 Nov; 22(11):1214-8. PubMed ID: 14613656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
